$-0.28 EPS Expected for Hancock Jaffe Laboratories, Inc. (HJLI); Phillips 66 Partners LP (PSXP) Has 1.04 Sentiment - The Moveefy

$-0.28 EPS Expected for Hancock Jaffe Laboratories, Inc. (HJLI); Phillips 66 Partners LP (PSXP) Has 1.04 Sentiment  The Moveefy

Analysts expect Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI) to report $-0.28 EPS on February, 6.After having $-0.13 EPS previously, Hancock Jaffe ...



Comments

Post a Comment

Popular posts from this blog

Orchestra BioMed™ Announces FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon for Treatment of Below-the-Knee Peripheral Artery Disease - Vascular Disease Management

Orchestra BioMed™ Announces FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon for Treatment of Below-the-Knee Peripheral Artery Disease    Vascular Disease Management First and only non-coated sirolimus-eluting angioplasty balloon system to receive Breakthrough Device designation for below-the-knee disease; Follows ...
Read more